Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 37, 2005 - Issue 1
Submit an article Journal homepage
148
Views
9
CrossRef citations to date
0
Altmetric
Short Communication

Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: An empiric study

Charlotte Jensen From the Unit of Gastrointestinal Infections, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark
,
Peter Schiellerup From the Unit of Gastrointestinal Infections, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, DenmarkCorrespondence[email protected]
,
Katharina E.P. Olsen From the Unit of Gastrointestinal Infections, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark
,
Flemming Scheutz From the Unit of Gastrointestinal Infections, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark; The International Escherichia and Klebsiella Centre (WHO Reference Centre), Statens Serum Institut, Copenhagen, Denmark
,
Eskild Petersen From the Unit of Gastrointestinal Infections, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark
,
Peter Gerner-Smidt From the Unit of Gastrointestinal Infections, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark
&
Kåre Mølbak From the Unit of Gastrointestinal Infections, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Copenhagen, Denmark; Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
 show all
Pages 61-63 | Received 08 Jul 2004, Accepted 06 Oct 2004, Published online: 08 Jul 2009

References

  • Nataro JP, Kaper JB. Diarrhoeagenic Escherichia coli. Clin Microbiol Rev 1998;11:142–201.
  • Chin J. Control of Communicable Diseases Manual. American Public Health Association. 17th edn. 2000.
  • Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the haemolytic-uraemic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000;342: 1930–6.
  • Kimmitt PT, Harwood CR, Barer MR. Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 2000;6:458–65.
  • Anonymous, 2004. Annual Report on Zoonoses in Denmark 2003, Ministry of Food, Agriculture and Fisheries.
  • Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr 1992;121: 303.
  • Ohara T, Kojio S, Taneike I, Nakagawa S, Gondaira F, Tamura Y, et al. Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. Antimicrob Agents Chemother 2002;46:3478–83.
  • Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, et al. Escherichia coli harbouring shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002;185:74–84.
  • Eklund M, Leino KF, Siitonen A. Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol 2002;40:4585–93.
  • Bonnet R, Souweine B, Gauthier G, Rich C, Livrelli V, Sirot J, et al. Non-O157:H7 stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic- uremic syndrome in adults. J Clin Microbiol 1998;36:1777–80.
  • Ethelberg S, Olsen KEP, Scheutz F, Jensen C, Schiellerup P, Engberg J, et al. Virulence factors for haemolytic uraemic syndrome, Denmark. Emerg Infect Dis 2004;10:842–7.
  • Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. Associations between virulence factors of shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 1999;37:497–503.
  • Karch H. The role of virulence factors in enterohaemorrhagic Escherichia coli (EHEC)-associated haemolytic- uraemic syndrome. Semin Thromb Hemost 2001;27: 207–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.